The Convergence of Telehealth and Medical Devices

Telehealth is no longer an emergency measure adopted during a pandemic. It is a permanent feature of healthcare delivery that is reshaping how medical device manufacturers reach clinicians, influence purchasing decisions, and support patient outcomes. In 2024, telehealth visits accounted for approximately 17% of all outpatient encounters in the United States, down from the pandemic peak of 40% but vastly higher than the pre-2020 baseline of 1%. This sustained adoption represents a structural shift that device manufacturers cannot afford to ignore.

For medical device companies, telehealth platforms are not just distribution channels for virtual care. They are marketing ecosystems where clinical workflows, device utilization data, and physician engagement intersect. A surgical robotics company that integrates training modules into a telehealth platform reaches surgeons in their daily workflow. A remote monitoring device manufacturer that partners with a telehealth vendor creates a seamless patient experience that drives adoption and retention.

The opportunity is substantial. The global telehealth market is projected to exceed $380 billion by 2028, growing at a compound annual growth rate of 24.3%. Within this market, connected medical devices represent the fastest-growing segment, driven by chronic disease management, post-surgical monitoring, and hospital-at-home programs. Companies that develop effective telehealth platform marketing strategies today will capture disproportionate market share as virtual care becomes standard practice.

This article provides a comprehensive framework for medical device manufacturers looking to market through, to, and alongside telehealth platforms. For broader context on commercial strategy, our medical device marketing guide covers the full spectrum of go-to-market planning for device companies.

Understanding the Telehealth Platform Ecosystem

Before developing a telehealth marketing strategy, manufacturers must understand the platform ecosystem and where their devices fit within it. The telehealth landscape is not monolithic. It consists of distinct platform categories, each offering different marketing opportunities.

Enterprise Telehealth Platforms

Platforms like Epic's MyChart Video Visits, Teladoc Health, and Amwell serve large health systems and payer organizations. These platforms handle millions of visits annually and integrate deeply with electronic health records. For device manufacturers, enterprise platforms represent an opportunity to embed device data, clinical decision support tools, and training content directly into the clinical workflow.

Marketing to enterprise platforms requires a B2B2C approach. You are not selling directly to patients or individual physicians. You are selling to platform operators and health system IT committees who evaluate integration complexity, security requirements, and clinical value propositions.

Specialty-Specific Telehealth Platforms

Platforms like Doxy.me, SimplePractice, and specialty-specific solutions in dermatology, behavioral health, and cardiology serve niche clinical communities. These platforms often have smaller user bases but deeper engagement within their specialty. A device manufacturer serving dermatologists, for example, might find more productive marketing partnerships with a dermatology-focused telehealth platform than with a general-purpose enterprise solution.

Remote Patient Monitoring Platforms

Companies like Biobeat, Vivify Health, and Health Recovery Solutions provide platforms specifically designed to collect, transmit, and analyze data from connected devices. These platforms are natural partners for device manufacturers because they depend on hardware to generate the data their software analyzes. Joint marketing initiatives between RPM platforms and device manufacturers create compelling integrated solutions for health systems.

Direct-to-Consumer Telehealth

Platforms like Hims & Hers, Ro, and Cerebral connect patients directly with providers. For consumer-facing medical devices such as continuous glucose monitors, home blood pressure monitors, or sleep apnea devices, DTC telehealth platforms offer a channel to reach patients at the moment of clinical engagement.

Marketing Strategies for Telehealth Platform Partnerships

Effective telehealth platform marketing requires strategies tailored to the partnership model. The following approaches have proven successful for medical device manufacturers navigating the telehealth ecosystem.

Integration-Led Marketing

The most powerful telehealth marketing strategy is integration. When your device data flows seamlessly into a telehealth platform, your product becomes part of the clinical workflow rather than an add-on. This creates switching costs, drives utilization, and generates organic advocacy from clinicians who rely on the integrated experience.

Consider how Abbott's FreeStyle Libre continuous glucose monitor integrates with telehealth platforms. When a patient's glucose data appears automatically in the telehealth visit interface, the physician can review trends, adjust medications, and counsel the patient without leaving the platform. The device is not just a product being marketed. It is an embedded component of the care delivery experience.

To execute integration-led marketing, invest in API development, FHIR-compliant data standards, and technical documentation that reduces the integration burden for platform partners. The easier you make it for platforms to integrate your device, the more partnerships you will secure.

Co-Marketing Partnerships

Joint marketing agreements with telehealth platforms allow both parties to leverage each other's audiences and credibility. A device manufacturer might co-author a white paper with a telehealth platform demonstrating improved patient outcomes when remote monitoring is combined with virtual physician visits. Both companies promote the content to their respective audiences, expanding reach while sharing costs.

Co-marketing can also include joint webinars, shared conference booth presence, coordinated press releases, and bundled solution marketing. The key is ensuring that both parties bring complementary value. The platform provides reach and clinical workflow integration; the device provides the clinical data and outcomes that make the platform more valuable.

Clinical Evidence Marketing

Telehealth platform buyers, whether they are health system CIOs, CMOs, or payer medical directors, make decisions based on clinical evidence. Device manufacturers that can demonstrate how their products improve outcomes within a telehealth context have a significant competitive advantage.

Invest in clinical studies that specifically evaluate device performance in telehealth-enabled care models. A study showing that patients using your remote cardiac monitor in conjunction with a telehealth follow-up protocol had 32% fewer hospital readmissions is far more compelling than generic device efficacy data. This evidence becomes the cornerstone of your telehealth marketing strategy.

Free: Medical Device Marketing Guide

Get our comprehensive strategy guide covering surgeon targeting, FDA compliance, SEO, and more.

Download the Guide →

Content Marketing for Telehealth-Connected Devices

Content marketing plays a critical role in educating both clinicians and patients about the value of telehealth-connected medical devices. The content strategy must address different audiences at different stages of the adoption journey.

Clinician-Facing Content

Physicians and advanced practice providers need to understand how your device integrates with their telehealth workflow, what data it provides, and how to interpret that data in a virtual care context. Create content that addresses practical clinical questions rather than product features.

This clinical content should be optimized for search visibility. Our healthcare SEO services help medical device companies create content strategies that capture physician search intent around telehealth-related clinical questions.

Health System Decision-Maker Content

Hospital administrators, IT directors, and procurement committees evaluate telehealth-connected devices based on operational efficiency, cost savings, and patient satisfaction metrics. Create content that speaks their language.

Patient-Facing Content

For consumer-facing devices, patient education content drives adoption and compliance. Patients need to understand how to use the device, how their data reaches their physician through the telehealth platform, and why consistent monitoring matters.

Regulatory Considerations for Telehealth Device Marketing

Marketing medical devices in a telehealth context introduces regulatory complexities that manufacturers must navigate carefully. The intersection of FDA device regulations, telehealth-specific state laws, and digital health guidance creates a compliance landscape that varies by product type, claim, and geography.

FDA Considerations

The FDA's 2023 guidance on "Policy for Device Software Functions and Mobile Medical Applications" clarifies how software that connects devices to telehealth platforms is regulated. If your device's telehealth integration includes clinical decision support functions, those functions may be subject to additional regulatory requirements.

Marketing claims about device performance in a telehealth context must be supported by the device's cleared or approved indications for use. If your 510(k) clearance specifies use in a clinical setting, marketing the device for home-based telehealth monitoring may require additional regulatory submissions.

State Telehealth Laws

Telehealth regulations vary significantly by state. Some states have parity laws requiring insurers to reimburse telehealth visits at the same rate as in-person visits, while others have more restrictive policies. Your marketing messages about reimbursement and coverage must accurately reflect the regulatory landscape in each state where you market your device.

Tennessee, for example, has enacted telehealth parity legislation that supports reimbursement for remote monitoring services, which is relevant for device manufacturers marketing to health systems in the Southeast.

HIPAA and Data Privacy

When device data flows through telehealth platforms, HIPAA compliance extends to the data transmission, storage, and display chain. Your marketing materials should clearly communicate your device's HIPAA compliance posture, including encryption standards, Business Associate Agreement (BAA) coverage, and data handling practices.

Measuring Telehealth Marketing Effectiveness

Telehealth marketing metrics differ from traditional medical device marketing metrics because the sales cycle involves platform partnerships, clinical workflows, and patient engagement in addition to device procurement.

Platform Partnership Metrics

Clinical Adoption Metrics

Patient Engagement Metrics

Case Study: Remote Cardiac Monitoring and Telehealth Integration

Consider how the remote cardiac monitoring market illustrates effective telehealth platform marketing. Companies like iRhythm (Zio patch), BioTelemetry (now Philips), and AliveCor (KardiaMobile) have built marketing strategies centered on telehealth integration.

iRhythm's Zio patch generates continuous ECG data over a 14-day monitoring period. The company's marketing emphasizes not just the device's diagnostic accuracy but its integration with telehealth workflows. When a cardiologist conducts a virtual follow-up visit, Zio data is available within the EHR, enabling informed clinical discussions without requiring the patient to come to the office.

This integration-first approach has contributed to iRhythm's growth, with the company reporting over 4.7 million Zio patches applied through 2024. The marketing message is not "buy our patch." It is "integrate better cardiac monitoring into your virtual care program."

AliveCor takes a different approach, targeting the consumer end of the telehealth spectrum. Their KardiaMobile device pairs with a smartphone app that enables patients to record FDA-cleared ECGs at home and share them with physicians during telehealth visits. Their marketing emphasizes patient empowerment and convenience, targeting health-conscious consumers through digital advertising, content marketing, and partnerships with DTC telehealth platforms.

Building a Telehealth Channel Strategy

Medical device manufacturers should approach telehealth as a channel strategy, not a one-off marketing initiative. This requires organizational alignment across marketing, product development, regulatory affairs, and business development.

Organizational Readiness

Assign dedicated resources to telehealth channel development. This might include a telehealth partnerships manager within business development, a product manager focused on platform integration, and a marketing lead responsible for telehealth-specific content and campaigns. Companies that treat telehealth as a side project within existing roles rarely achieve meaningful traction.

Platform Selection and Prioritization

Not every telehealth platform is a viable marketing partner. Prioritize platforms based on user base size, clinical specialty alignment, integration openness (API availability, FHIR support), and commercial model compatibility. Start with two to three strategic partnerships rather than pursuing a dozen superficial relationships.

Go-to-Market Playbook

Develop a repeatable playbook for launching on new telehealth platforms. This playbook should cover technical integration requirements, co-marketing agreement templates, sales enablement materials, and success metrics. A standardized approach reduces time-to-market for each new platform partnership.

Long-Term Platform Strategy

Telehealth platforms are consolidating. Large players are acquiring specialty platforms, and health system-owned solutions are gaining market share. Your telehealth channel strategy should anticipate this consolidation by maintaining relationships with both incumbent platforms and emerging contenders. Diversification reduces the risk of overexposure to any single platform partner.

The Future of Telehealth Device Marketing

Several trends will shape telehealth platform marketing for medical device manufacturers over the next three to five years.

AI-powered clinical decision support: As telehealth platforms integrate artificial intelligence for triage, diagnosis support, and treatment recommendations, device data will become a critical input to AI algorithms. Manufacturers that provide structured, high-quality data will become preferred partners for AI-enabled platforms.

Hospital-at-home programs: CMS's Acute Hospital Care at Home waiver has enabled over 300 hospitals to provide acute-level care in patients' homes. These programs depend heavily on connected medical devices and telehealth platforms, creating a new market segment for device manufacturers.

Payer-driven adoption: Commercial insurers and Medicare Advantage plans are increasingly covering remote monitoring services, driven by evidence that connected care reduces total cost of care. As reimbursement expands, device utilization in telehealth settings will grow correspondingly.

International expansion: Telehealth adoption is accelerating globally, with the EU, UK, Japan, and emerging markets developing regulatory frameworks and reimbursement policies for virtual care. Device manufacturers with established telehealth marketing capabilities in the U.S. will be well-positioned to replicate those strategies internationally.

Our medical device marketing team works with manufacturers across the telehealth spectrum, from connected monitoring devices to surgical robotics platforms, helping them develop integrated marketing strategies that capture the telehealth opportunity.

The manufacturers that will lead in the telehealth era are those that view platforms not as technology vendors but as strategic marketing channels that connect devices to clinicians and patients in the context of care delivery. Building those connections requires investment in integration, evidence, content, and partnerships, but the return is a sustainable competitive advantage in a market that is growing faster than almost any other segment in healthcare.